Markus Mobs

Markus Mobs

Berlin, BE 12203, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications

Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC.

Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC.

Journal: The oncologist
Published: February 13, 2026

Author Correction: Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets.

Author Correction: Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets.

Journal: Molecular systems biology
Published: December 02, 2025

DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.

DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.

Journal: Cell reports. Medicine
Published: November 28, 2025

Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma.

Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma.

Journal: British journal of cancer
Published: November 03, 2025

Targetable alterations and personalized treatment in ameloblastoma: results from a prospective observational precision oncology study.

Targetable alterations and personalized treatment in ameloblastoma: results from a prospective observational precision oncology study.

Journal: NPJ precision oncology
Published: September 09, 2025

Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma.

Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma.

Journal: The journal of pathology. Clinical research
Published: July 10, 2025

Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets.

Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets.

Journal: Molecular systems biology
Published: April 15, 2025

Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients.

Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients.

Journal: Cancers
Published: March 05, 2025

Mucinous cystic neoplasms of the pancreas and liver share a similar DNA methylation profile with mucinous ovarian tumors.

Mucinous cystic neoplasms of the pancreas and liver share a similar DNA methylation profile with mucinous ovarian tumors.

Journal: The Journal of pathology
Published: February 09, 2025

Implementation and outcome of personalized treatment strategies in advanced genitourinary cancers.

Implementation and outcome of personalized treatment strategies in advanced genitourinary cancers.

Journal: ESMO open
Published: February 06, 2025

Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysis.

Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysis.

Journal: European journal of cancer (Oxford, England : 1990)
Published: September 02, 2024

Benchmarking whole exome sequencing in the German network for personalized medicine.

Benchmarking whole exome sequencing in the German network for personalized medicine.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 20, 2024
Showing 1-12 of 48

Last Updated: 09/26/2026